Dec 18 (Reuters) - Pharmaxis Ltd PXS.AX :
* BOEHRINGER INGELHEIM AND PHARMAXIS DISCONTINUED THE DEVELOPMENT OF BI 1467335 FOR THE TREATMENT OF NASH
Dec 18 (Reuters) - Pharmaxis Ltd PXS.AX :
* BOEHRINGER INGELHEIM AND PHARMAXIS DISCONTINUED THE DEVELOPMENT OF BI 1467335 FOR THE TREATMENT OF NASH